SuperworthImmix Biopharma shares outstanding IMMX
Diluted shares outstanding, averaged over each quarter, from 2022.
- Latest quarter, to Jun 30, 2026
- 63.8M
- On a year earlier
- +112.7%
- more shares
Immix Biopharma had 63.8M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 112.7% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 40.1M | +36% |
| FY2024 | 29.6M | +36% |
| FY2023 | 21.7M | +56% |
| FY2022 | 13.9M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 63.8M | +113% | |
| Q1 FY26 | 55.4M | +86% | |
| Q4 FY25 | 40.1M | +36% | |
| Q3 FY25 | 31.9M | +9% | |
| Q2 FY25 | 30M | +4% | |
| Q1 FY25 | 29.7M | +27% | |
| Q4 FY24 | 29.6M | +36% | |
| Q3 FY24 | 29.4M | +58% | |
| Q2 FY24 | 28.8M | +91% | |
| Q1 FY24 | 23.4M | +69% | |
| Q4 FY23 | 21.7M | +56% | |
| Q3 FY23 | 18.6M | +33% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Immix Biopharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.